Not everyone has the same risk level or risk tolerance. Just stay away from other people and your risk should be close to zero.pmanton said:We're 82 and 80. My wife is a heart patient. We DON'T want to catch this. Luckily we live on an airpark in rural AZ, so we're isolated.
Dimwits here are still doing buggy rides, happy hour, fly-outs for breakfast etc.
My fear is that they won't go home for the Summer. (We're full time residents)
Well, the serious models and preprints say basically that social distancing is unlikely to be sufficient in the US and may make things worse in the fall, if SARS Cov-2 is mildly seasonal.chemgeek said:Social distancing is especially important if you don't know who is spreading the virus. It's pretty much the only tool without testing. With testing isolation can be more targeted, and immune individuals turned loose.
The 0.3% lethality rate comes from the study in Germany where they tested a random sample of households and 1000 people. That is the best estimate of the actual lethality rate of those infected, versus confirmed cases, for the general population which we presently have. It is likely much more lethal for the elderly and those with pre-existing conditions. That study also found 15% of the population with antibodies.Kenny Phillips said:A conona doesn't mean THE corona; many cold viruses are coronaviruses.
Of those with confirmed cases of COVID-19 in the USA, nearly 4% are dying. I find that to be a harrowing number. And, since not 100% of the population has been tested, we don't know how many have been exposed. (I would love to see 100% of the population tested, eventually.) I would be quite happy if 15% of the population had been exposed, not gotten sick, and thus were out of the system.
Should sheltering in place / isolation / quarantine been strictly voluntary? I have my opinion on that, but I also have knowledge of what humans will actually do.
Can you provide a citation for the Iceland publication you are referring to? I found the recent article by Stock et al (http://www.igmchicago.org/wp-content/uploads/2020/04/Covid_Iceland_v10.pdf) but that estimated an 90% of cases asymptomatic, so I assume that is not what you are referring to.chemgeek said:We already have three published studies that have provided estimates of case and infection fatality rates from comprehensive testing of relatively closed populations of individuals: the Diamond Princess passengers (3000+), the village of Vo, Italy (about 3600), and a study in Iceland that tested approximately 10% of their population.
I agree these seem to be the best estimates about now. I would not describe that as "much more explosively" from a qualitative perspective. The measles, which is highly contagious, has an R0 of about 16. But the numbers are really the most informative.The R0 for influenza is around 1.3, whereas COVID-19 is around 2.3-2.6, which means it spreads much more explosively than the flu.
The preprint is in German here https://www.land.nrw/sites/default/...chenergebnis_covid19_case_study_gangelt_0.pdf .chemgeek said:I haven't yet been able to review a preprint or peer-reviewed publication of that study to understand what assumptions they made to arrive at that number from their serological testing.
I think in terms of the sort of parameters being discussed here, a vaccine affects the R0 value, which is not a fixed item for a particular virus. As you immunize more of the population, fewer additional cases are infected for each case, thus reducing R0.Jeff Oslick said:We keep hearing these comparisons to the fatality rate for influenza, without recognizing that many influenza infections and deaths are prevented by fairly widespread use of the flu vaccines, particularly among the most vulnerable populations. If you remove the effect of flu vaccine use from the analysis I think the COVID-19 fatality rate would look much more comparable.
Likely better to state a number, rather than qualitative descriptions, which can be misleading. The estimated R0 for SARS-Cov-2 is about 2X that for the seasonal flu.chemgeek said:The intrinsic R0 for influenza is about 1.3, which is much lower than the estimated intrinsic R0 for SARS-CoV-2..
While the point is well taken taken that the doubling rate depends on R0, the relationship depends on the latency assumed in a model and has a different form than the equation given. (https://en.wikipedia.org/wiki/Basic_reproduction_number).chemgeek said:It is "much lower" because the R0 is an exponential factor, as in e^(r0*t). If you double the R0, you halve the doubling time. That's a very big deal for exponential growth. (5 doublings is 32x initial; 10 doublings in the same time period is 1024x initial. Huge difference in growth of raw numbers.) Measles is one of the most contagious diseases known, undoubtedly. Covid-19 has an R0 about double that of seasonal flu, based on current knowledge.
I would very much like to see a publication and careful study of this sort with appropriate control for population density etc. Haven’t seen that yet.chemgeek said:Well, in NY, the effective R0 was reduced from 1.8 to 0.9 in about 4 weeks. The reduction can't be attributed to herd immunity, because only a small fraction of the population has been infected.
What happens in the last two weeks? Is that supposed to be a data point at the end, or just an artifact? Or a point for the whole two weeks? And did you add that?deonb said:Here you go. Comparing deaths from all causes.
It's 2 weeks old though - take that red line on the right and double it.
View attachment 84838
I will be very curious to see when the numbers come out. In Europe as of about a week ago, total mortality was actually down somewhat, excepting Italy.deonb said:Ignore my 2-week thing, it's only a complication. There will be new data at the end of April. The point was just that even for the half we have right now, the count is much larger than any previous total deaths-from-all-causes count, including 9/11.
For #1. While the contrast between Kentucky and Tennessee is often held out as proof that social distancing works, epidemiologists in Tennessee note that actual measures of distancing obtained from cell phone records indicate more compliance in Tennessee, yet that is the state with the higher number of cases, so they don’t buy the explanation that differences in social distancing policies are the explanation.chemgeek said:I'm not sure I understand points 1 and 2.
Can you provide the data and your analysis? I have not had the time to try and pull this together myself yet but would be very happy to see it.The NY state data is an excellent case in point. You can (and I have) compared that data to other states and also to the US as a whole, excluding NY state, which was one of the first and earliest to implement stay-at-home policies. The difference in that data is stark, and if conforms very nicely to the expected outcome.
Well we have preprints on all sorts of other aspects of this. You say you’ve already performed an analysis. I imagine those who work in this area specifically have had plenty of time to do something similar. Where are those preprints? Perhaps they will be forthcoming, but until they do so, I think it is a bit premature to predict what they will say.It is probably too early to have peer-reviewed publications on this topic, because we are still in the middle of the outbreak.
I agree that the results from the recent studies in the US strongly suggest herd immunity is likely not a factor, at least not in the normal sense.Regarding point 4. There is no good evidence, even if one considers extremely optimistic estimates of exposure rates, that herd immunity is a factor in the current progress of the epidemic in the US.
What did you think of the validation procedures in the recent Stanford study? They manufacturer reportedly had something like 390 negatives against sera from prior to the epidemic.A proper study would include validation data (something analytical chemists are quite familiar with) to ensure it is not picking up false positives from non-COVID coronaviruses, which are very common.
Argument from authority. I’ll be convinced by the data, analysis, and publications. Where are they?There is overwhelming scientific consensus points to the importance of physical distancing in controlling the current outbreak.
Again, please provide citations. I have seen no preprints addressing this. Without citations to at least preprints, it seems unjustified to assert this.There is virtually no disagreement (I mean, is there really ANY disagreement on this point?) that physical distancing has reduced both morbidity and mortality due to COVID-19, and publicly available data supports that claim.
Agreed the cost trade offs are not a scientific question and that in the limit distancing has to work to stop the spread. The question is whether in this case the interventions used have worked, and if so, how well.If people are not exposed, they can't get sick and they can't die from the virus. Balancing economic and public health issues is another thing, and that is a question of ethics and sociology, not science.
Interesting, the numbers from that article about Chelsea would suggest an infection fatality rate of 0.33%. This is in rough agreement with the results in Gangelt and about 50% more, relatively speaking, than the estimates from the Santa Clara study of 0.12-0.2%. All are much lower than the feared 8% from initial reports and in an absolute sense on the same order as the seasonal flu for infection fatality rate.MuseChaser said:50 to 85 TIMES more people. Therefore, the mortality rate would seem to also be 50 to 85 times lower than previously reported.
What I am particularly curious about is the comparison which you said you made that shows clearly that the times of implementation of coercive and voluntary policies for distancing correlate with a change in the in the growth rate of the infections.chemgeek said:You can find the data on GitHub and explore to your heart's content. JHU has the largest dataset, although it can be harder to navigate. The NY Times has simplified and re-aggregated that dataset for confirmed cases and deaths, aggregated by states and counties in separate files. That dataset has the same data in an easier to use format.
The US national rate of confirmed cases appears to be a linear growth mode for the last two weeks, quite strongly so actually. That strikes me as quite odd and indicating some other type of limited process. Other people have speculated it may reflect a limit on the number of tests which can be processed per day, but I have been unable to find a serious reference on that.Nationwide, the inflection point is a moving target (hasn't been reached yet) and logistic curve analysis points to somewhere north of 60,000 deaths. That's if nothing changes from the current situation.
Curious, what did you think of the controls which were run by the manufacturer of the kits used in the Santa Clara study? They tested against 371 pre-Covid samples with 369 negative results. It strikes me that argues that that test is not reacting with other coronaviruses which were around at the time, though I suppose depending on where the pre-Covid samples were obtained, they might not have contained the other coronaviruses.chemgeek said:Many if not all,of the current test kits are using antigens that have significant cross-reactivity with other common coronavirus strains that cause the common cold. False positives are going to be very prevalent, especially considering that the true negatives are expected to be 85-95% of the test pool. ELISA assays are notorious in the research lab for their ability to be insufficiently specific.
No of course the confirmed cases are not a straight line overall. The question is, if you look at this on a log scale, once there were a reasonable number of cases it appeared to be on an exponential growth curve. Then for the last 4 weeks it has looked quite linear. See attached.chemgeek said:Both the US overall or NY state data has not grown linearly. You can see that by simply examining a full plot of the raw data. It's not a straight line. Both caseload and deaths data has closely followed a canonical logistic curve, which is a self-limiting exponential growth function typical of phenomena like epidemics.